S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
U.S. stocks traded mixed toward the trading, with the Dow Jones index falling around 0.2% on Friday. The…
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday’s session following fourth-quarter results. AMMO reported a fourth-quarter profit…
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares moved upwards by 37.4% to $2.9 during Friday’s regular session. The market value…
Gold Gains 1%; US Consumer Sentiment Falls In June
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points on…
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
U.S. stocks traded mostly lower this morning, with the Dow Jones index dipping more than 200 points on…
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Adobe Inc. (NASDAQ:ADBE) rose sharply in today’s pre-market trading following better-than-expected second-quarter earnings and strong guidance.…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Ainos (NASDAQ:AIMD) stock rose 54.8% to $1.27 during Friday’s pre-market session. The market value of their outstanding…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Cue Health (NASDAQ:HLTH) stock moved upwards by 44.2% to $0.08 during Thursday’s pre-market session. The market value…
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Gain Therapeutics’ CEO Matthias Alder Issues Letter To Shareholders
Dear Fellow Stockholders,With the start of a new year, I want to take a moment to reflect on Gain's progress over the last 12 months and to share our strategy and plans for 2024.Research and development of pharmaceutical